Regencell Bioscience Holdings Limited
Reports in 36d· 2026-06-02
-9.6% · 90d
$29.20
+1.71 (+6.22%)
News
(1)March 2026
Regencell Bioscience Holdings Ltd — 6-K Filing
RGCRegencell Bioscience Holdings Ltd
# 🧾 What This Document Is This is a "current report" (Form 6-K) filed with the SEC. It's not a routine earnings report. Think of it as an important, timely announcement from Regencell. The core news is that the company has set up a financing tool to sell up to **$500 million** of its stock over tim
Read summaryView on SEC EDGAR
Peers in Drug Manufacturers - Specialty & Generic
TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%
ALKS#11
Alkermes plc
$5.81B+0.43%